Cardiovascular Ultrasound (Jun 2008)

Effects of cognac on coronary flow reserve and plasma antioxidant status in healthy young men

  • Lehtimäki Terho,
  • Pärkkä Jussi P,
  • Raitakari Olli T,
  • Saraste Markku,
  • Toikka Jyri O,
  • Saraste Antti,
  • Kiviniemi Tuomas O,
  • Hartiala Jaakko J,
  • Viikari Jorma,
  • Koskenvuo Juha W

DOI
https://doi.org/10.1186/1476-7120-6-25
Journal volume & issue
Vol. 6, no. 1
p. 25

Abstract

Read online

Abstract Background The cardioprotective effects of certain alcoholic beverages are partly related to their polyphenol content, which may improve the vasodilatory reactivity of arteries. Effect of cognac on coronary circulation, however, remains unknown. The purpose of this randomized controlled cross-over study was to determine whether moderate doses of cognac improve coronary reactivity as assessed with cold pressor testing (CPT) and coronary flow reserve (CFR) measument. Methods Study group consisted of 23 subjects. Coronary flow velocity and epicardial diameter was assessed using transthoracic echocardiography at rest, during CPT and adenosine infusion-derived CFR measurements before drinking, after a moderate (1.2 ± 0.1 dl) and an escalating high dose (total amount 2.4 ± 0.3 dl) of cognac. To explore the bioavailability of antioxidants, the antioxidant contents of cognac was measured and the absorption from the digestive tract was verified by plasma antioxidant capacity determination. Results Serum alcohol levels increased to 1.2 ± 0.2‰ and plasma antioxidant capacity from 301 ± 43.9 μmol/l to 320 ± 25.0 μmol/l by 7.6 ± 11.8%, (p = 0.01) after high doses of cognac. There was no significant change in flow velocity during CPT after cognac ingestion compared to control day. CFR was 4.4 ± 0.8, 4.1 ± 0.9 (p = NS), and 4.5 ± 1.2 (p = NS) before drinking and after moderate and high doses on cognac day, and 4.5 ± 1.4, and 4.0 ± 1.2 (p = NS) on control day. Conclusion Cognac increased plasma antioxidant capacity, but it had no effect on coronary circulation in healthy young men. Trial Registration NCT00330213